NCT05447156

Brief Summary

Aim 3: To test feasibility, acceptability, and preliminary efficacy of the tailored QuitGuide for smoking cessation among AIs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
115

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 1, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 7, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

December 14, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 25, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 29, 2023

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

April 11, 2025

Completed
Last Updated

April 11, 2025

Status Verified

March 1, 2025

Enrollment Period

10 months

First QC Date

July 1, 2022

Results QC Date

December 5, 2024

Last Update Submit

March 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Frequency of App Use

    The number of times the app is initiated per day will be measured using data from Smokefree.gov. If a participant does not use the app on a particular day, Smokefree.gov records this as non-use or 0 for that day. The total number of times will be summarized for analysis by totaling the number of times the app is initiated from randomization to 5 weeks post-randomization.

    5 weeks post enrollment and 1 week post randomization

Secondary Outcomes (5)

  • Study Attrition Measured as Percentage of Randomized Participants That Complete the Final Phone Interview at 5 Weeks

    5 weeks post enrollment aim 3

  • Frequency of Returning Saliva Sample by 2 Weeks Post the Week 5 Interview

    5 weeks post enrollment aim 3

  • Usability of App Design Measured Using System Usability Scale (SUS)

    5 weeks post enrollment

  • Acceptability of Overall App

    5 weeks post enrollment

  • Fit of App With Culture

    5 weeks post enrollment

Study Arms (2)

Aim 3:Tailored App

EXPERIMENTAL

Randomized subset of participants will use the tailored QuitGuide app, a smoking cessation app, downloaded to their personal phone.

Behavioral: Tailored QuitGuide app

Aim 3: Standard App

PLACEBO COMPARATOR

Randomized subset of participants will use the standard QuitGuide app, a smoking cessation app available to the public, downloaded to their personal phone.

Behavioral: Standard QuitGuide app

Interventions

This is an app not available to the public. It was developed/tailored based on an app available to the public and can be downloaded.

Aim 3:Tailored App

This is an app available to the public.

Aim 3: Standard App

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Indian person based on self-report
  • Age ≥ 18 years
  • Interested in quitting smoking
  • Smoke ≥ 3 commercial tobacco cigarette per day (CPD) in the past 30 days
  • o Use of other commercial tobacco products (e.g., e-cigarettes) is permitted if they report cigarettes being their primary product
  • Smartphone ownership with the ability to download applications and sufficient data to complete research procedures

You may not qualify if:

  • New or change in pharmacotherapy for smoking cessation (includes: nicotine gum, patch, lozenge, inhaler OR medications Chantix/Wellbtrutin/Zyban/Bupropion) in past month
  • Does not speak or read English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Masonic Cancer Center - University of Minnesota

Minneapolis, Minnesota, 55455, United States

Location

MeSH Terms

Conditions

Tobacco UseTobacco Use Disorder

Condition Hierarchy (Ancestors)

BehaviorSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Results Point of Contact

Title
Dana Mowls Carroll, Ph.D., M.P.H.
Organization
Masonic Cancer Center

Study Officials

  • Dana Caroll, PhD

    Masonic Cancer Center, Univeristy of Minnesota

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Aim 3: Participants will be randomized to either the tailored QuitGuide app or the standard version of the QuitGuide app for 5 weeks.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 1, 2022

First Posted

July 7, 2022

Study Start

December 14, 2022

Primary Completion

September 25, 2023

Study Completion

November 29, 2023

Last Updated

April 11, 2025

Results First Posted

April 11, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations